Press Releases

Low-dose aspirin found to have no effect on healthy life span in seniors


Elena Volpi, M.D., Ph.D. Elena Volpi, M.D., Ph.D.
By utmb | September 17, 2018

The University of Texas Medical Branch at Galveston participated in an international study finding that low-dose aspirin therapy in older healthy adults without previous cardiovascular events did not prolong healthy independent living.

UTMB’s Sealy Center on Aging was one of 34 clinical sites in the United States taking part in the ASPirin in Reducing Events in the Elderly trial.

“This is a critically important study because many older adults who never had a heart attack or a stroke are taking aspirin,” says Dr. Elena Volpi, principal investigator of the UTMB clinical site. “In this study aspirin did not protect from developing dementia or physical disability, but it increased the risk of death.”

More than 19,000 people 65 and older in the United States and Australia participated in the ASPREE study, which began in 2010 to see if aspirin would increase survival free of persistent physical disability or dementia.

Upon enrolling, participants could not have dementia or a physical disability and had to be free of medical conditions requiring aspirin use. Individuals with stable chronic diseases, such as high blood pressure or diabetes, were included in the study. Participants were followed an average of 4.7 years to determine outcomes.

ASPREE researchers found that the rates for major cardiovascular events, including coronary heart disease, nonfatal heart attacks, and fatal and nonfatal ischemic stroke were similar for those taking aspirin when compared to those taking a placebo.

The increased risk of death found in participants taking aspirin appeared to be mostly due to cancer deaths. However, the researchers urge caution saying those findings indicate a need for more long-term studies.

Researchers also examined the risk of major bleeding; a recognized side effect of aspirin use, and found a significant increase in bleeding risk with aspirin. This finding was consistent with results from many other aspirin studies.

The takeaway message is that for healthy people over 70, like the ones enrolled in ASPREE, daily use of low-dose aspirin does not appear to extend a healthy life span.

Leaders of the ASPREE team include John McNeil of Monash University, Australia and Anne Murray of the Berman Center for Outcomes and Clinical Research at Hennepin Healthcare in Minneapolis.

The study, published in three papers in The New England Journal of Medicine, received support from the National Institute on Aging and the National Cancer Institute.

Tags |



Social Posts

profile_image

University of Houston

@UHouston

RT @Wmjohnst: YA WOOOO COUGAR FOOTBALL #YWCF https://t.co/wydYxRJMF5

16 mins ago
profile_image

University of Houston

@UHouston

RT @TornadoISR: #GoCoogs #HTownTakeover #ywcf 🐾🏈🐾🏈🐾🏈 https://t.co/kghNbwtz1u

16 mins ago
profile_image

University of Houston

@UHouston

Let's do this! #HTownTakeover #YWCF https://t.co/sG8VP6IzIf

17 mins ago
profile_image

Veterans Affairs

@DeptVetAffairs

Veteran finds new purpose helping military families https://t.co/8ZHpBY9x5t via @wusa9

27 mins ago
profile_image

Houston Methodist

@MethodistHosp

@ehaasmd Thanks for sharing the photos.

41 mins ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

What is #protontherapy and what types of cancer can it treat? https://t.co/r63xWsEgr4 @mdaprotons #endcancer https://t.co/yP6k35iFhV

43 mins ago
profile_image

Houston Methodist

@MethodistHosp

@TheCAOG Thanks for sharing the photo.

44 mins ago
profile_image

Houston Methodist

@MethodistHosp

@BCMDeptMedicine Thanks for sharing the info.

52 mins ago
profile_image

Veterans Affairs

@DeptVetAffairs

At the Vietnam Memorial, a Lake Geneva Veteran bumps into a fellow Vet he hasn't seen in 48 years https://t.co/g1Cj0rXus9 via @620wtmj

1 hour ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

“This study is proof of principle that we should keep going,” says our @JenniferLitton. #immunotherapy #bcsm #endcancer https://t.co/zUbvJvOqQF

2 hours ago
profile_image

Veterans Affairs

@DeptVetAffairs

Holocaust survivors visit museum with World War II Veterans https://t.co/JJOCvMt4U6 via @ABC7News

2 hours ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

Learn how an #immunotherapy clinical trial gave #melanoma survivor Karlee Steele a chance to help other patients. #endcancer https://t.co/6OCovaOl5N

3 hours ago
profile_image

Texas Children's

@TexasChildrens

A revolutionary treatment for allergies to peanuts and other foods is going mainstream—but do the benefits outweigh the risks? Learn more via @sciencemagazine: https://t.co/NopMMWUDha #texaschildrens

3 hours ago
profile_image

BCMHouston

@bcmhouston

Congratulations to the Dr. David Persse on receiving the American College of Emergency Physician's 2018 Outstanding Contribution to EMS award. https://t.co/olQqIQpndd

3 hours ago
profile_image

CHI St. Luke's Health

@CHI_StLukes

Join us for our FREE event featuring multiple #childbirth and newborn education classes, door prizes, and a #HospitalTour. Get your tickets today: https://t.co/b8skGCLUG6 https://t.co/njd8HFqHxn

4 hours ago